UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study

Annals of oncology, 2024-01, Vol.35 (1), p.77-90

2024

Volltextzugriff (PDF)

Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma

Annals of oncology, 2018-09, Vol.29 (9), p.1995-2002

2018

Volltextzugriff (PDF)

Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in patients with advanced ovarian cancer: exploratory analysis of the phase 3 OVA-301 study

Annals of oncology, 2015-05, Vol.26 (5), p.914-920

2015

Volltextzugriff (PDF)

JNJ-61186372 (JNJ-372), an EGFR-cMET bispecific antibody, in advanced non-small cell lung cancer (NSCLC): An update on phase I results

Annals of oncology, 2018-10, Vol.29, p.viii542-viii542

2018

Volltextzugriff (PDF)

Efficacy and safety of trabectedin or dacarbazine for the treatment of patients with uterine leiomyosarcoma after prior chemotherapy: A subgroup analysis of the randomized phase 3 SAR-3007 study

Gynecologic oncology, 2016-06, Vol.141, p.3-3

2016

Volltextzugriff (PDF)

Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in subjects with advanced ovarian cancer: Exploratory analysis of phase III OVA-301 study

Gynecologic oncology, 2014-06, Vol.133, p.41-41

2014

Volltextzugriff (PDF)

Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr

Journal of Virology, 1995-12, Vol.69 (12), p.7909-7916

1995

Volltextzugriff (PDF)

7056 POSTER QT/QTc Studies of Abiraterone Acetate in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) – Analysis of 3 Phase 1/2 Studies

European journal of cancer (1990), 2011, Vol.47, p.S502-S502

2011

Volltextzugriff (PDF)

Efficacy and safety of trabectedin in an elderly patient subgroup (≥65 years) with advanced leiomyosarcoma (LMS) or liposarcoma (LPS) from the Expanded Access Program (EAP)

Annals of oncology, 2017-09, Vol.28, p.v529

2017

Volltextzugriff (PDF)

P50.04 Amivantamab in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S1116-S1116

2021

Volltextzugriff (PDF)

OA15.03 Amivantamab in Non-small Cell Lung Cancer (NSCLC) with MET Exon 14 Skipping (METex14) Mutation: Initial Results from CHRYSALIS

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S874-S875

2021

Volltextzugriff (PDF)

P2.07-058 First-In-Human Study of JNJ-64041757, a Live Attenuated Listeria Monocytogenes Immunotherapy, for Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2151-S2151

2017

Volltextzugriff (PDF)

Efficacy and safety of patients treated long-term with trabectedin (t) on the expanded access program: A retrospective analysis

Annals of oncology, 2017-09, Vol.28, p.v529

2017

Volltextzugriff (PDF)

1497PJNJ-61186372 (JNJ-372), an EGFR-cMET bispecific antibody, in advanced non-small cell lung cancer (NSCLC): An update on phase I results

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

OA10.06 A First-in-Human Phase 1 Trial of the EGFR-cMET Bispecific Antibody JNJ-61186372 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S344-S345

2018

Volltextzugriff (PDF)

Targeting tumor metabolism: biguanides as anti-neoplastic agents

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e14592-e14592

2009

Volltextzugriff (PDF)

Role for Hsp90-Associated Cochaperone p23 in Estrogen Receptor Signal Transduction

Molecular and Cellular Biology, 1999-05, Vol.19 (5), p.3748-3759

1999

Volltextzugriff (PDF)

Rho GTPases as Modulators of the Estrogen Receptor Transcriptional Response

The Journal of biological chemistry, 2001-02, Vol.276 (5), p.3231-3237

2001

Volltextzugriff (PDF)

Sudden death and Wegener's granulomatosis of the pituitary: Case Report

Scandinavian journal of rheumatology, 2000-01, Vol.29 (4), p.264-266

2000

Volltextzugriff (PDF)

Genetic Dissection of p23, an Hsp90 Cochaperone, Reveals a Distinct Surface Involved in Estrogen Receptor Signaling

The Journal of biological chemistry, 2003-09, Vol.278 (38), p.36547-36555

2003

Volltextzugriff (PDF)

Toxicity of argatroban overdose in a 65‐year‐old man

American journal of hematology, 2005-07, Vol.79 (3), p.248-249

2005

Volltextzugriff (PDF)

Etiology and therapy of essential hypertension

Hippokrates, 1953-10, Vol.24 (20), p.634

KNOBLAUCH, R

1953

Volltextzugriff (PDF)

Infection with L-organisms

Zeitschrift fur Haut- und Geschlechtskrankheiten, 1952-06, Vol.12 (11), p.469

KNOBLAUCH, R

1952

Volltextzugriff (PDF)

On the etiology and therapy of nonspecific catarrhal urethritis

Zeitschrift fur Haut- und Geschlechtskrankheiten, 1951-11, Vol.11 (10), p.407

KNOBLAUCH, R

1951

Volltextzugriff (PDF)

Benefits and Costs of Ultraviolet Fluorescent Lighting

Traffic injury prevention, 2002-09, Vol.3 (3), p.209-215

2002

Volltextzugriff (PDF)

1 – 25 von 311

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(240)
Mit Volltextzugriff
(226)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(168)
Life Sciences & Biomedicine
(125)
Humans
(121)
Female
(71)
Male
(68)
Adult
(62)
Middle Aged
(47)
Biological And Medical Sciences
(41)
Aged
(32)
Physical Sciences
(31)
Medical Sciences
(26)
Animals
(24)
Adolescent
(23)
Technology
(23)
Biochemistry & Molecular Biology
(21)
Fundamental And Applied Biological Sciences. Psychology
(18)
Physics
(17)
Oncology
(16)
Genetics & Heredity
(15)
Child
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study

Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma

Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in patients with advanced ovarian cancer: exploratory analysis of the phase 3 OVA-301 study

JNJ-61186372 (JNJ-372), an EGFR-cMET bispecific antibody, in advanced non-small cell lung cancer (NSCLC): An update on phase I results

Efficacy and safety of trabectedin or dacarbazine for the treatment of patients with uterine leiomyosarcoma after prior chemotherapy: A subgroup analysis of the randomized phase 3 SAR-3007 study

Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in subjects with advanced ovarian cancer: Exploratory analysis of phase III OVA-301 study

Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr

7056 POSTER QT/QTc Studies of Abiraterone Acetate in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) – Analysis of 3 Phase 1/2 Studies

Efficacy and safety of trabectedin in an elderly patient subgroup (≥65 years) with advanced leiomyosarcoma (LMS) or liposarcoma (LPS) from the Expanded Access Program (EAP)

P50.04 Amivantamab in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

OA15.03 Amivantamab in Non-small Cell Lung Cancer (NSCLC) with MET Exon 14 Skipping (METex14) Mutation: Initial Results from CHRYSALIS

P2.07-058 First-In-Human Study of JNJ-64041757, a Live Attenuated Listeria Monocytogenes Immunotherapy, for Non-Small Cell Lung Cancer

Efficacy and safety of patients treated long-term with trabectedin (t) on the expanded access program: A retrospective analysis

1497PJNJ-61186372 (JNJ-372), an EGFR-cMET bispecific antibody, in advanced non-small cell lung cancer (NSCLC): An update on phase I results

OA10.06 A First-in-Human Phase 1 Trial of the EGFR-cMET Bispecific Antibody JNJ-61186372 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

Targeting tumor metabolism: biguanides as anti-neoplastic agents

Role for Hsp90-Associated Cochaperone p23 in Estrogen Receptor Signal Transduction

Rho GTPases as Modulators of the Estrogen Receptor Transcriptional Response

Sudden death and Wegener's granulomatosis of the pituitary: Case Report

Genetic Dissection of p23, an Hsp90 Cochaperone, Reveals a Distinct Surface Involved in Estrogen Receptor Signaling

Toxicity of argatroban overdose in a 65‐year‐old man

Etiology and therapy of essential hypertension

Infection with L-organisms

On the etiology and therapy of nonspecific catarrhal urethritis

Benefits and Costs of Ultraviolet Fluorescent Lighting

Suchergebnisse filtern